Literature DB >> 24784862

Population health and burden of disease profile of Iran among 20 countries in the region: from Afghanistan to Qatar and Lebanon.

Saeid Shahraz1, Mohammad Hossein Forouzanfar2, Sadaf G Sepanlou2, Daniel Dicker2, Paria Naghavi2, Farshad Pourmalek3, Ali Mokdad2, Rafael Lozano2, Theo Vos2, Mohsen Asadi-Lari4, Ali-Akbar Sayyari5, Christopher J L Murray2, Mohsen Naghavi2.   

Abstract

BACKGROUND: Population health and disease profiles are diverse across Iran's neighboring countries. Borrowing the results of the country-level Global Burden of Diseases, Injuries, and Risk Factors 2010 Study (GBD 2010), we aim to compare Iran with 19 countries in terms of an important set of population health and disease metrics. These countries include those neighboring Iran and a few other countries from the Middle East and North Africa (MENA) region.
METHODS: We show the pattern of health transition across the comparator countries from 1990 through 2010. We use classic GBD metrics measured for the year 2010 to indicate the rank of Iran among these nations. The metrics include disability-adjusted life years (DALYs), years of life lost as a result of premature death (YLLs), years of life lost due to disability (YLDs), health-adjusted life expectancy (HALE), and age-standardized death rate (ASD).
RESULTS: Considerable and uniform transition from communicable, maternal, neonatal, and nutritional (CMMN) conditions to non-communicable diseases (NCDs) was seen between 1990 and 2010. On average, ischemic heart disease, lower respiratory infections, and road injuries were the three principal causes of YLLs, while low back pain and major depressive disorders were the top causes of YLDs in these countries. Iran ranked 13th in HALE and 12th in ASD. The function of Iran's health care, measured by DALYs, was somewhat in the middle of the HALE spectrum for the comparator countries. This intermediate position becomes rather highlighted when Afghanistan, as outlier, is taken out of the comparison.
CONCLUSION: Effective policies to reduce NCDs need to be formulated and implemented through an integrated health care system. Our comparison shows that Iran can learn from the experience of a number of these countries to devise and execute the required strategies.

Entities:  

Mesh:

Year:  2014        PMID: 24784862     DOI: 0141705/AIM.006

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  20 in total

1.  Socio-economic status and chronic disease in the West Bank and the Gaza Strip: in and outside refugee camps.

Authors:  Marie Jonassen; Amira Shaheen; Mohammed Duraidi; Khaled Qalalwa; Bernard Jeune; Henrik Brønnum-Hansen
Journal:  Int J Public Health       Date:  2018-06-14       Impact factor: 3.380

2.  Ultra-Early versus Early Excision and Grafting for Thermal Burns up to 60% Total Body Surface Area; A Historical Cohort Study.

Authors:  Abdolkhalegh Keshavarzi; Mehdi Ayaz; Maryam Dehghankhalili
Journal:  Bull Emerg Trauma       Date:  2016-10

3.  Cardiovascular disease mortality and years of life lost attributable to non-optimal systolic blood pressure and hypertension in northeastern Iran.

Authors:  Sadaf G Sepanlou; Roger B Newson; Hossein Poustchi; Masoud M Malekzadeh; Parisa Rezanejad Asl; Arash Etemadi; Hooman Khademi; Farhad Islami; Akram Pourshams; Paul D Pharoah; Christian C Abnet; Paul Brennan; Paolo Bofetta; Sanford M Dawsey; Farin Kamangar; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2015-03       Impact factor: 1.354

4.  Twenty-Six-Year Trend of Mortality Rate Due to Ischemic Heart Diseases (IHDs) in Iran: 1990-2015.

Authors:  Shohreh Naderimagham; Kimiya Gohari; Ali Sheidaei; Hamidreza Jamshidi; Alireza Namazi Shabestari; Mitra Modirian; Nazila Rezaei; Farzad Kompani; Bahman Damerchilu; Hamidreza Bahrami-Taghanaki; Bagher Larijani; Farshad Farzadfar
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

5.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

6.  Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran.

Authors:  Fatemeh Rezaei; Mozhgan Seif; Abdullah Gandomkar; Mohammad Reza Fattahi; Jafar Hasanzadeh
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

7.  The clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in North-East of Iran.

Authors:  Sadaf G Sepanlou; Reza Malekzadeh; Hossein Poustchi; Maryam Sharafkhah; Saeed Ghodsi; Fatemeh Malekzadeh; Arash Etemadi; Akram Pourshams; Paul D Pharoah; Christian C Abnet; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Farin Kamangar
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

8.  Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010.

Authors:  Fatemeh Malekzadeh; Sadaf Ghajarieh Sepanlou; Hossein Poustchi; Mohsen Naghavi; Mohammad Hossein Forouzanfar; Saeid Shahraz; Maziar Moradi-Lakeh; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2015-07

9.  Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010.

Authors:  Sadaf Ghajarieh Sepanlou; Fatemeh Malekzadeh; Mohsen Naghavi; Mohammad Hossein Forouzanfar; Saeid Shahraz; Maziar Moradi-Lakeh; Reza Malekzadeh; Hossein Poustchi
Journal:  Middle East J Dig Dis       Date:  2015-07

10.  Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive.

Authors:  Hesam Ghiasvand; Mohammad Moradi-Joo; Nazanin Abolhassani; Hamid Ravaghi; Seyed Mansoor Raygani; Sahar Mohabbat-Bahar
Journal:  Med J Islam Repub Iran       Date:  2016-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.